Published in Prog Med Virol on January 01, 1990
Natural isolates of simian virus 40 from immunocompromised monkeys display extensive genetic heterogeneity: new implications for polyomavirus disease. J Virol (1998) 1.30
Activation of the tumor-specific death effector apoptin and its kinase by an N-terminal determinant of simian virus 40 large T antigen. J Virol (2004) 0.97
Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period. Br J Cancer (2001) 0.86
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J Natl Cancer Inst (1999) 0.84
Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40. Orphanet J Rare Dis (2006) 0.84
Childhood cancers: what is a possible role of infectious agents? Infect Agent Cancer (2013) 0.80
Polyomaviruses of nonhuman primates: implications for research. Comp Med (2008) 0.76
Development of anaplastic ependymoma in Rasmussen's encephalitis: review of the literature and case report. Childs Nerv Syst (2005) 0.75